To view this, you need to install the Flash Player 5. Please go to here and download it.

Personal Injury Blog

Device Used in Hysterectomies May Cause the Spread of Cancer

November 24, 2014 @ 01:23 PM — by Jim Pettit
Tagged with:

Today the FDA warned against using a medical device called "Laparoscopic Power Morcellators" to remove uterus fibroids (i.e., hysterectomies). In fact, the FDA Notice was categorized as an "Immediately In Effect " (IIE) Guidance. In addition the FDA recommended that the companies that make the Laparoscopic Power Morcellators include safety statements in the form of "Boxed Warnings" and two (2) Contraindications. The boxed warning should include the fact that these devices may actually cause the spread of existing cancer which would decrease the long-term survival of patients. 

Jury Awards $155,000 to Actos Victim

November 18, 2014 @ 04:17 PM — by Jim Pettit
Tagged with:
An injured plaintiff was awarded $155,000 in West Virginia for his Actos-related bladder cancer. The jury was only out three hours before it rendered its verdict. This verdict followed right on the heels of a Philadelphia jury verdict of $2 million to another former Actos user. In the recent trial the judge allowed the lawyer for the plaintiff to argue that defendant, Takeda, intentionally destroyed many of its Actos development and marketing files. The US spokesperson for Takeda said that the company is considering its options, which would include an appeal. There are more than 8,000 Actos cases filed around the country, with over 3,500 filed in federal court (which is where Locks Law Firm LLC files its Actos cases).  

Toxic Chemicals, Benzene Concentrations Increase Exponentially by Fracking Sites

November 12, 2014 @ 02:22 PM — by Admin
Tagged with:

In a world increasingly concerned about available sources of energy, scientific innovations have opened the door to new methods of obtaining natural gas and oil. One such method, known as hydraulic fracturing – or fracking – functions as a double-edged sword because it permits energy companies to obtain previously unreachable sources of energy, but poses significant environmental and health risks.

The risks of hydraulic fracturing are manifesting as it was recently proven that eight poisonous chemicals were found near fracking sites in Pennsylvania, Arkansas, Colorado, Ohio and Wyoming. Benzene, a carcinogen linked to leukemia and cancer, was the most common chemical found near fracking sites.  Additionally, researchers from Yale and the University of Washington determined that residents who lived within a kilometer of a fracking well had up to twice the number of health problems as those living at least two kilometers away...

Your cosmetic products may contain asbestos!

November 03, 2014 @ 11:17 AM — by Jim Pettit
Tagged with:

Thousands of consumer products contain that fine powder called talc. In a recent study, scientists from three different laboratories discuss the fact that talc mines can be contaminated with the deadly mineral, asbestos. Doctors, researchers and lawyers representing plaintiffs have looked at patients with mesothelioma (a rare, fatal form of cancer caused by asbestos) and have sometimes struggled to find the source of the asbestos exposure that caused the mesothelioma, a cancer caused only by asbestos. If, for example, a woman diagnosed with mesothelioma never worked near asbestos, nor did her husband, it can sometimes be difficult to ascertain the source of the asbestos exposure. The existence of asbestos in baby powder, women's cosmetic products, men's barbershop powder,  and other products is a serious health concern.

Actos Defendant has found some of its missing documents

October 20, 2014 @ 12:25 PM — by Jim Pettit
Tagged with:
The defendant manufacturer in the Actos litigation, Takeda Pharmaceutical, has very recently advised the federal court in Louisiana that it has now found over 61,000 e-mails and attachments consisting of more than 330,000 pages. Takeda had previously been sanctioned by the court for spoliation of documents for 46 of its custodians of records. Indeed, attorneys for plaintiffs have been permitted by the court to tell the jury about Takeda's spoliation of this evidence. Locks Law Firm LLC represents patients who took Actos for their Type-2 diabetes and who subsequently developed bladder cancer.  Those cases were filed in federal court in New Jersey and were transferred to the federal multi-district litigation ("MDL") and so are being managed by Judge Rebecca Doherty in the Western District of Louisiana. If you or a loved one developed bladder cancer after using Actos, please contact Locks Law Firm today.  Our Pennsylvania, New Jersey and New York attorneys c

So-called tort reform does not decrease costs or reduce testing ordered by doctors

October 16, 2014 @ 04:47 PM — by Jim Pettit
The forces behind so-called tort reform (more accurately named tort deform) argue that tort reform legislation will save consumers money because doctors will not have to perform what is erroneously called 'defensive medicine" (that is, ordering tests so the doctor does not get sued). A study presented in the prestigious New England Journal of Medicine (October 16, 2014) shows that in three (3) so-called tort reform states, emergency room doctors basically ordered the same tests as before. There was no reduction in costs. Another inference one could reasonably draw from this study is that most doctors probably do not indulge in so-called "defensive medicine" in order not to be sued,  but rather most doctors probably order testing for the benefit of their patients.

Actos Verdict for Plaintiff

October 08, 2014 @ 10:49 AM — by Jim Pettit
Tagged with:

A jury in Philadelphia found defendant, Takeda, liable for over $2 million for failing to warn that its drug, Actos, can cause bladder cancer, and for causing a 79-year-old woman's bladder cancer. During the three-week-plus trial,  Takeda had argued that smoking or other causes were to blame. There have now been seven (7) trials involving claims that Actos caused bladder cancer. The largest verdict, $9 billion earlier this year, is being appealed by Takeda. Two verdicts in favor of plaintiffs (California and Maryland) which combined totalled $8.2 million, were overturned by the trial judge. Three verdicts (two in Las Vegas and one in Illinois) were defense verdicts in favor of Takeda. Evidence shows that Takeda officials destroyed documents about Actos. Actos is a Type-2 diabetes drug which  has generated over $16 billion in sales since it was released in 1999. 

Fungal Meningitis Lawsuit Filed

September 24, 2014 @ 04:31 PM — by Jim Pettit
Tagged with:
Locks Law Firm LLC has filed suit for a patient who received a fungal-contaminated steroid injection in his spine, causing fungal meningitis. The steroid product came from New England Compounding Center ("NECC") in Massachusetts. Federal officials shut down NECC in 2012 because NECC was producing lots of methylprednisolone acetate (MPA) which were contaminated. The Center for Disease Control (CDC) states the contaminated steroids caused 64 deaths and hundreds of patients were caused to have meningitis. Approximately 45 cases have been filed in New Jersey and many more have been filed around the country. There are about 300 cases in the federal Multidistrict Litigation (MDL). 

Johnson & Johnson withdrawing surgical tool that can spread cancer in women

August 01, 2014 @ 10:08 AM — by Admin

On Wednesday, July 30th, Johnson & Johnson announced it was withdrawing a surgical tool that can spread cancer in women.  This voluntary recall removed the devices made by the largest manufacturer of those devices from the market amid a contentious debate over its use.

The company planned to tell customers world-wide in a letter to return the devices known as laparoscopic power morcellators. J&J already suspended sales of new morcellators in April after the U.S. Food and Drug Administration advised doctors not to use the tool, which slices up common uterine masses called fibroids, and uteruses themselves, into fragments so they can be removed in minimally invasive surgery. In April, J&J defended the safety of the tool but said it was waiting for more guidance from the medical community.

FDA to Require Blood Clot Warnings on Testosterone Products

June 23, 2014 @ 09:19 AM — by Admin

On June 20, 2014 the United States Food and Drug Administration announced that it would require the manufacturers of all approved testosterone products to include a warning in the drug labeling about the risk of blood clots in the veins, also known as venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE). See the FDA announcement here (http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm402054.htm)....

...The Locks Law Firm is actively investigating cases of stroke, heart attack, blood clots in the veins, pulmonary embolism and death in users of testosterone products, especially those prescribed for what is known as "low-T syndrome." If you, a friend or a loved one has used a testosterone gel, cream, patch or other testosterone formulation and suffered any of the conditions mentioned above, please contact the Locks Law Firm.

Share |

Back to top